Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by vikingguyon Jul 06, 2017 10:24pm

225 Views

Post# 26442891

RE:RE:RE:RE:RE:Price decrease

We have looked at comparables and Iba could definitely be approved 2-3 months before it's pdufa. September is optimistic but one thing is for certain.....after the summer break and markets start to pick up again, nobody will want to be caught without shares of TH. July could be flat but August is sure to continue the trend upwards.

I also believe a management team that has done all the right things so far will have a nice surprise or two up their sleeve to help us along the way. Take advantage of these dips everyone.

Bullboard Posts

Canadian artificial intelligence ETFs